Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 15.1660.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 15.16 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202515.16
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 15.16
-75.04
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹20,629.2 Cr -6.3% -5.3% -28.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,905.0 Cr -6.8% -7.6% -4.7% Stock Analytics
DIVIS LABORATORIES ₹159,357.0 Cr -6.6% -5.8% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,788.0 Cr 0.9% 5.7% 27.3% Stock Analytics
CIPLA ₹110,628.0 Cr -4.8% -8.1% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹96,441.5 Cr -2% -8.8% -12.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-6.3%

-5.3%

-28.8%

SENSEX

-2.1%

-3%

6.8%


You may also like the below Video Courses